Oncorus Inc. (ONCR): Price and Financial Metrics
ONCR Price/Volume Stats
| Current price | $0.13 | 52-week high | $0.47 |
| Prev. close | $0.13 | 52-week low | $0.01 |
| Day low | $0.13 | Volume | 135,900 |
| Day high | $0.20 | Avg. volume | 1,333,593 |
| 50-day MA | $0.03 | Dividend yield | N/A |
| 200-day MA | $0.12 | Market Cap | 3.29M |
ONCR Stock Price Chart Interactive Chart >
Oncorus Inc. (ONCR) Company Bio
Oncorus, Inc. engages in the research and development of viral immunotherapies platform. It develops immunotherapy platform to treat cancer such as oncolytic Herpes Simplex Virus Platform and Synthetic Virus Platform. The company was founded by Mitchell H. Finer, Joseph C. Glorioso III, Kenneth P. Greenberg, Cyrus D. Mozayeni, and Paola Grandi on April 1, 2015 and is headquartered in Cambridge, MA.
ONCR Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 519.05% |
| 3-year | -97.72% |
| 5-year | N/A |
| YTD | 3.17% |
| 2023 | -50.26% |
| 2022 | -95.19% |
| 2021 | -83.70% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...